table of content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Nuclear Medicine Isotopes Market Size Analysis from 2022 to 2027
1.5.1 Global Nuclear Medicine Isotopes Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Nuclear Medicine Isotopes Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Nuclear Medicine Isotopes Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Nuclear Medicine Isotopes Industry Impact
Chapter 2 Global Nuclear Medicine Isotopes Competition by Types, Applications, and Top Regions and Countries
2.1 Global Nuclear Medicine Isotopes (Volume and Value) by Type
2.1.1 Global Nuclear Medicine Isotopes Consumption and Market Share by Type (2016-2021)
2.1.2 Global Nuclear Medicine Isotopes Revenue and Market Share by Type (2016-2021)
2.2 Global Nuclear Medicine Isotopes (Volume and Value) by Application
2.2.1 Global Nuclear Medicine Isotopes Consumption and Market Share by Application (2016-2021)
2.2.2 Global Nuclear Medicine Isotopes Revenue and Market Share by Application (2016-2021)
2.3 Global Nuclear Medicine Isotopes (Volume and Value) by Regions
2.3.1 Global Nuclear Medicine Isotopes Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Nuclear Medicine Isotopes Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Nuclear Medicine Isotopes Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Nuclear Medicine Isotopes Consumption by Regions (2016-2021)
4.2 North America Nuclear Medicine Isotopes Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Nuclear Medicine Isotopes Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Nuclear Medicine Isotopes Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Nuclear Medicine Isotopes Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Nuclear Medicine Isotopes Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Nuclear Medicine Isotopes Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Nuclear Medicine Isotopes Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Nuclear Medicine Isotopes Sales, Consumption, Export, Import (2016-2021)
4.10 South America Nuclear Medicine Isotopes Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Nuclear Medicine Isotopes Market Analysis
5.1 North America Nuclear Medicine Isotopes Consumption and Value Analysis
5.1.1 North America Nuclear Medicine Isotopes Market Under COVID-19
5.2 North America Nuclear Medicine Isotopes Consumption Volume by Types
5.3 North America Nuclear Medicine Isotopes Consumption Structure by Application
5.4 North America Nuclear Medicine Isotopes Consumption by Top Countries
5.4.1 United States Nuclear Medicine Isotopes Consumption Volume from 2016 to 2021
5.4.2 Canada Nuclear Medicine Isotopes Consumption Volume from 2016 to 2021
5.4.3 Mexico Nuclear Medicine Isotopes Consumption Volume from 2016 to 2021
Chapter 6 East Asia Nuclear Medicine Isotopes Market Analysis
6.1 East Asia Nuclear Medicine Isotopes Consumption and Value Analysis
6.1.1 East Asia Nuclear Medicine Isotopes Market Under COVID-19
6.2 East Asia Nuclear Medicine Isotopes Consumption Volume by Types
6.3 East Asia Nuclear Medicine Isotopes Consumption Structure by Application
6.4 East Asia Nuclear Medicine Isotopes Consumption by Top Countries
6.4.1 China Nuclear Medicine Isotopes Consumption Volume from 2016 to 2021
6.4.2 Japan Nuclear Medicine Isotopes Consumption Volume from 2016 to 2021
6.4.3 South Korea Nuclear Medicine Isotopes Consumption Volume from 2016 to 2021
Chapter 7 Europe Nuclear Medicine Isotopes Market Analysis
7.1 Europe Nuclear Medicine Isotopes Consumption and Value Analysis
7.1.1 Europe Nuclear Medicine Isotopes Market Under COVID-19
7.2 Europe Nuclear Medicine Isotopes Consumption Volume by Types
7.3 Europe Nuclear Medicine Isotopes Consumption Structure by Application
7.4 Europe Nuclear Medicine Isotopes Consumption by Top Countries
7.4.1 Germany Nuclear Medicine Isotopes Consumption Volume from 2016 to 2021
7.4.2 UK Nuclear Medicine Isotopes Consumption Volume from 2016 to 2021
7.4.3 France Nuclear Medicine Isotopes Consumption Volume from 2016 to 2021
7.4.4 Italy Nuclear Medicine Isotopes Consumption Volume from 2016 to 2021
7.4.5 Russia Nuclear Medicine Isotopes Consumption Volume from 2016 to 2021
7.4.6 Spain Nuclear Medicine Isotopes Consumption Volume from 2016 to 2021
7.4.7 Netherlands Nuclear Medicine Isotopes Consumption Volume from 2016 to 2021
7.4.8 Switzerland Nuclear Medicine Isotopes Consumption Volume from 2016 to 2021
7.4.9 Poland Nuclear Medicine Isotopes Consumption Volume from 2016 to 2021
Chapter 8 South Asia Nuclear Medicine Isotopes Market Analysis
8.1 South Asia Nuclear Medicine Isotopes Consumption and Value Analysis
8.1.1 South Asia Nuclear Medicine Isotopes Market Under COVID-19
8.2 South Asia Nuclear Medicine Isotopes Consumption Volume by Types
8.3 South Asia Nuclear Medicine Isotopes Consumption Structure by Application
8.4 South Asia Nuclear Medicine Isotopes Consumption by Top Countries
8.4.1 India Nuclear Medicine Isotopes Consumption Volume from 2016 to 2021
8.4.2 Pakistan Nuclear Medicine Isotopes Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Nuclear Medicine Isotopes Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Nuclear Medicine Isotopes Market Analysis
9.1 Southeast Asia Nuclear Medicine Isotopes Consumption and Value Analysis
9.1.1 Southeast Asia Nuclear Medicine Isotopes Market Under COVID-19
9.2 Southeast Asia Nuclear Medicine Isotopes Consumption Volume by Types
9.3 Southeast Asia Nuclear Medicine Isotopes Consumption Structure by Application
9.4 Southeast Asia Nuclear Medicine Isotopes Consumption by Top Countries
9.4.1 Indonesia Nuclear Medicine Isotopes Consumption Volume from 2016 to 2021
9.4.2 Thailand Nuclear Medicine Isotopes Consumption Volume from 2016 to 2021
9.4.3 Singapore Nuclear Medicine Isotopes Consumption Volume from 2016 to 2021
9.4.4 Malaysia Nuclear Medicine Isotopes Consumption Volume from 2016 to 2021
9.4.5 Philippines Nuclear Medicine Isotopes Consumption Volume from 2016 to 2021
9.4.6 Vietnam Nuclear Medicine Isotopes Consumption Volume from 2016 to 2021
9.4.7 Myanmar Nuclear Medicine Isotopes Consumption Volume from 2016 to 2021
Chapter 10 Middle East Nuclear Medicine Isotopes Market Analysis
10.1 Middle East Nuclear Medicine Isotopes Consumption and Value Analysis
10.1.1 Middle East Nuclear Medicine Isotopes Market Under COVID-19
10.2 Middle East Nuclear Medicine Isotopes Consumption Volume by Types
10.3 Middle East Nuclear Medicine Isotopes Consumption Structure by Application
10.4 Middle East Nuclear Medicine Isotopes Consumption by Top Countries
10.4.1 Turkey Nuclear Medicine Isotopes Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Nuclear Medicine Isotopes Consumption Volume from 2016 to 2021
10.4.3 Iran Nuclear Medicine Isotopes Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Nuclear Medicine Isotopes Consumption Volume from 2016 to 2021
10.4.5 Israel Nuclear Medicine Isotopes Consumption Volume from 2016 to 2021
10.4.6 Iraq Nuclear Medicine Isotopes Consumption Volume from 2016 to 2021
10.4.7 Qatar Nuclear Medicine Isotopes Consumption Volume from 2016 to 2021
10.4.8 Kuwait Nuclear Medicine Isotopes Consumption Volume from 2016 to 2021
10.4.9 Oman Nuclear Medicine Isotopes Consumption Volume from 2016 to 2021
Chapter 11 Africa Nuclear Medicine Isotopes Market Analysis
11.1 Africa Nuclear Medicine Isotopes Consumption and Value Analysis
11.1.1 Africa Nuclear Medicine Isotopes Market Under COVID-19
11.2 Africa Nuclear Medicine Isotopes Consumption Volume by Types
11.3 Africa Nuclear Medicine Isotopes Consumption Structure by Application
11.4 Africa Nuclear Medicine Isotopes Consumption by Top Countries
11.4.1 Nigeria Nuclear Medicine Isotopes Consumption Volume from 2016 to 2021
11.4.2 South Africa Nuclear Medicine Isotopes Consumption Volume from 2016 to 2021
11.4.3 Egypt Nuclear Medicine Isotopes Consumption Volume from 2016 to 2021
11.4.4 Algeria Nuclear Medicine Isotopes Consumption Volume from 2016 to 2021
11.4.5 Morocco Nuclear Medicine Isotopes Consumption Volume from 2016 to 2021
Chapter 12 Oceania Nuclear Medicine Isotopes Market Analysis
12.1 Oceania Nuclear Medicine Isotopes Consumption and Value Analysis
12.2 Oceania Nuclear Medicine Isotopes Consumption Volume by Types
12.3 Oceania Nuclear Medicine Isotopes Consumption Structure by Application
12.4 Oceania Nuclear Medicine Isotopes Consumption by Top Countries
12.4.1 Australia Nuclear Medicine Isotopes Consumption Volume from 2016 to 2021
12.4.2 New Zealand Nuclear Medicine Isotopes Consumption Volume from 2016 to 2021
Chapter 13 South America Nuclear Medicine Isotopes Market Analysis
13.1 South America Nuclear Medicine Isotopes Consumption and Value Analysis
13.1.1 South America Nuclear Medicine Isotopes Market Under COVID-19
13.2 South America Nuclear Medicine Isotopes Consumption Volume by Types
13.3 South America Nuclear Medicine Isotopes Consumption Structure by Application
13.4 South America Nuclear Medicine Isotopes Consumption Volume by Major Countries
13.4.1 Brazil Nuclear Medicine Isotopes Consumption Volume from 2016 to 2021
13.4.2 Argentina Nuclear Medicine Isotopes Consumption Volume from 2016 to 2021
13.4.3 Columbia Nuclear Medicine Isotopes Consumption Volume from 2016 to 2021
13.4.4 Chile Nuclear Medicine Isotopes Consumption Volume from 2016 to 2021
13.4.5 Venezuela Nuclear Medicine Isotopes Consumption Volume from 2016 to 2021
13.4.6 Peru Nuclear Medicine Isotopes Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Nuclear Medicine Isotopes Consumption Volume from 2016 to 2021
13.4.8 Ecuador Nuclear Medicine Isotopes Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Nuclear Medicine Isotopes Business
14.1 NRG
14.1.1 NRG Company Profile
14.1.2 NRG Nuclear Medicine Isotopes Product Specification
14.1.3 NRG Nuclear Medicine Isotopes Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Cambridge Isotope Laboratories
14.2.1 Cambridge Isotope Laboratories Company Profile
14.2.2 Cambridge Isotope Laboratories Nuclear Medicine Isotopes Product Specification
14.2.3 Cambridge Isotope Laboratories Nuclear Medicine Isotopes Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 ANSTO
14.3.1 ANSTO Company Profile
14.3.2 ANSTO Nuclear Medicine Isotopes Product Specification
14.3.3 ANSTO Nuclear Medicine Isotopes Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 NTP Radioisotopes
14.4.1 NTP Radioisotopes Company Profile
14.4.2 NTP Radioisotopes Nuclear Medicine Isotopes Product Specification
14.4.3 NTP Radioisotopes Nuclear Medicine Isotopes Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Curium Pharma
14.5.1 Curium Pharma Company Profile
14.5.2 Curium Pharma Nuclear Medicine Isotopes Product Specification
14.5.3 Curium Pharma Nuclear Medicine Isotopes Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 JSC Isotope
14.6.1 JSC Isotope Company Profile
14.6.2 JSC Isotope Nuclear Medicine Isotopes Product Specification
14.6.3 JSC Isotope Nuclear Medicine Isotopes Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 Polatom
14.7.1 Polatom Company Profile
14.7.2 Polatom Nuclear Medicine Isotopes Product Specification
14.7.3 Polatom Nuclear Medicine Isotopes Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 Nordion
14.8.1 Nordion Company Profile
14.8.2 Nordion Nuclear Medicine Isotopes Product Specification
14.8.3 Nordion Nuclear Medicine Isotopes Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 IRE
14.9.1 IRE Company Profile
14.9.2 IRE Nuclear Medicine Isotopes Product Specification
14.9.3 IRE Nuclear Medicine Isotopes Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.10 Eckert & Ziegler Strahlen
14.10.1 Eckert & Ziegler Strahlen Company Profile
14.10.2 Eckert & Ziegler Strahlen Nuclear Medicine Isotopes Product Specification
14.10.3 Eckert & Ziegler Strahlen Nuclear Medicine Isotopes Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.11 Shanghai Engineering Research Center
14.11.1 Shanghai Engineering Research Center Company Profile
14.11.2 Shanghai Engineering Research Center Nuclear Medicine Isotopes Product Specification
14.11.3 Shanghai Engineering Research Center Nuclear Medicine Isotopes Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.12 Linde
14.12.1 Linde Company Profile
14.12.2 Linde Nuclear Medicine Isotopes Product Specification
14.12.3 Linde Nuclear Medicine Isotopes Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.13 Center of Molecular Research
14.13.1 Center of Molecular Research Company Profile
14.13.2 Center of Molecular Research Nuclear Medicine Isotopes Product Specification
14.13.3 Center of Molecular Research Nuclear Medicine Isotopes Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.14 SI Science
14.14.1 SI Science Company Profile
14.14.2 SI Science Nuclear Medicine Isotopes Product Specification
14.14.3 SI Science Nuclear Medicine Isotopes Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.15 IDB Holland
14.15.1 IDB Holland Company Profile
14.15.2 IDB Holland Nuclear Medicine Isotopes Product Specification
14.15.3 IDB Holland Nuclear Medicine Isotopes Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.16 LANL
14.16.1 LANL Company Profile
14.16.2 LANL Nuclear Medicine Isotopes Product Specification
14.16.3 LANL Nuclear Medicine Isotopes Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.17 China National Nuclear Corporation
14.17.1 China National Nuclear Corporation Company Profile
14.17.2 China National Nuclear Corporation Nuclear Medicine Isotopes Product Specification
14.17.3 China National Nuclear Corporation Nuclear Medicine Isotopes Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.18 ORNL
14.18.1 ORNL Company Profile
14.18.2 ORNL Nuclear Medicine Isotopes Product Specification
14.18.3 ORNL Nuclear Medicine Isotopes Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.19 NHTC
14.19.1 NHTC Company Profile
14.19.2 NHTC Nuclear Medicine Isotopes Product Specification
14.19.3 NHTC Nuclear Medicine Isotopes Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.20 Urenco
14.20.1 Urenco Company Profile
14.20.2 Urenco Nuclear Medicine Isotopes Product Specification
14.20.3 Urenco Nuclear Medicine Isotopes Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Nuclear Medicine Isotopes Market Forecast (2022-2027)
15.1 Global Nuclear Medicine Isotopes Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Nuclear Medicine Isotopes Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Nuclear Medicine Isotopes Value and Growth Rate Forecast (2022-2027)
15.2 Global Nuclear Medicine Isotopes Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Nuclear Medicine Isotopes Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Nuclear Medicine Isotopes Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Nuclear Medicine Isotopes Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Nuclear Medicine Isotopes Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Nuclear Medicine Isotopes Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Nuclear Medicine Isotopes Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Nuclear Medicine Isotopes Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Nuclear Medicine Isotopes Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Nuclear Medicine Isotopes Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Nuclear Medicine Isotopes Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Nuclear Medicine Isotopes Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Nuclear Medicine Isotopes Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Nuclear Medicine Isotopes Consumption Forecast by Type (2022-2027)
15.3.2 Global Nuclear Medicine Isotopes Revenue Forecast by Type (2022-2027)
15.3.3 Global Nuclear Medicine Isotopes Price Forecast by Type (2022-2027)
15.4 Global Nuclear Medicine Isotopes Consumption Volume Forecast by Application (2022-2027)
15.5 Nuclear Medicine Isotopes Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
